Abby Douglas
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 6
- Co-authors
- Monica A. SlavinJason A. TrubianoElizabeth J. PhillipsKyra ChuaNatasha E. HolmesSara VogrinKarin ThurskyOlivia Smibert
- Journals
- Open Forum Infectious Diseases (5 papers)The Journal of Allergy and Clinical Immunology In Practice (4 papers)Current Opinion in Infectious Diseases (4 papers)Clinical Infectious Diseases (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Abby Douglas
36 papers receiving 907 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Toxicology 121
- Applied Microbiology and Biotechnology 67
- Immunology and Allergy 178
- Pharmacology 484
- Dermatology 226
Countries citing papers authored by Abby Douglas
This map shows the geographic impact of Abby Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Douglas more than expected).
Fields of papers citing papers by Abby Douglas
This network shows the impact of papers produced by Abby Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Douglas. The network helps show where Abby Douglas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abby Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 33 | |
| 11 | 2020 | 23 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 11 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 22 | |
| 16 | 2018 | 7 | |
| 17 | 2018 | 50 | |
| 18 | 2016 | 74 | |
| 19 | 2016 | 6 | |
| 20 | 2010 | 24 |
About Abby Douglas
Abby Douglas is a scholar working on Applied Microbiology and Biotechnology, Toxicology, Clinical Biochemistry, Infectious Diseases and Pharmacology, having authored 40 papers that have together received 917 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (13 papers), Antifungal resistance and susceptibility (11 papers), Neutropenia and Cancer Infections (9 papers), Fungal Infections and Studies (9 papers), Bacterial Identification and Susceptibility Testing (7 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Hematological disorders and diagnostics (6 papers). The work is most often cited by research in Toxicology (121 citations), Applied Microbiology and Biotechnology (67 citations), Immunology and Allergy (178 citations), Pharmacology (484 citations) and Dermatology (226 citations). Abby Douglas has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Monica A. Slavin, Jason A. Trubiano, Elizabeth J. Phillips, Kyra Chua, Natasha E. Holmes, Sara Vogrin, Karin Thursky, Olivia Smibert, S.C.-A. Chen and Misha Devchand. Their work appears in journals such as Open Forum Infectious Diseases, The Journal of Allergy and Clinical Immunology In Practice, Current Opinion in Infectious Diseases, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.